Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 3546 entries
View as:

Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

Phase: N/A Priority: Normal
NCT ID: NCT02153333 Org: User:
Start: 02/28/14 End: 12/31/14 Due: 12/31/15

Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT02262702 Org: User:
Start: 01/31/13 End: 01/31/13 Due: 01/31/14

A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays

Phase: N/A Priority: Normal
NCT ID: NCT00637351 Org: User:
Start: 03/31/08 End: 02/28/09 Due: 02/28/10

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Phase: N/A Priority: Normal
NCT ID: NCT05921903 Org: User:
Start: 07/28/23 End: 06/02/25 Due: 06/02/26

Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01347060 Org: User:
Start: 07/31/09 End: 04/30/10 Due: 04/30/11

Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT03136120 Org: User:
Start: 11/21/17 End: 11/13/18 Due: 11/13/19

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

Phase: N/A Priority: Normal
NCT ID: NCT04010539 Org: User:
Start: 10/21/19 End: 10/10/23 Due: 10/10/24

A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Phase: N/A Priority: Normal
NCT ID: NCT04718103 Org: User:
Start: 02/04/21 End: 04/11/24 Due: 04/11/25

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT01475721 Org: User:
Start: 11/18/11 End: 06/23/15 Due: 06/23/16

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04136145 Org: User:
Start: 10/28/19 End: 01/14/20 Due: 01/14/21

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00146744 Org: User:
Start: 07/31/05 End: 05/31/06 Due: 05/31/07

A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

Phase: N/A Priority: Normal
NCT ID: NCT02213029 Org: User:
Start: 08/28/14 End: 02/07/16 Due: 02/07/17

A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Phase: N/A Priority: Normal
NCT ID: NCT01440361 Org: User:
Start: 03/31/13 End: 04/30/15 Due: 04/30/16

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01563055 Org: User:
Start: 04/30/12 End: 11/30/14 Due: 11/30/15

A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00537043 Org: User:
Start: 10/31/07 End: 01/31/08 Due: 01/31/09

Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population

Phase: N/A Priority: Normal
NCT ID: NCT01615783 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Phase: N/A Priority: Normal
NCT ID: NCT00335881 Org: User:
Start: 06/30/06 End: 11/30/06 Due: 11/30/07

Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02750930 Org: User:
Start: 10/07/16 End: 03/21/17 Due: 03/21/18

Booster and Catch-up Vaccination With Vaccine GSK1024850A

Phase: N/A Priority: Normal
NCT ID: NCT01030822 Org: User:
Start: 04/02/10 End: 08/19/11 Due: 08/19/12

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00805389 Org: User:
Start: 12/15/08 End: 07/14/11 Due: 07/14/12

Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00406003 Org: User:
Start: 03/24/06 End: 04/26/06 Due: 04/26/07

Phase 1 Study of GSK2315698 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02953808 Org: User:
Start: 11/30/16 End: 12/31/16 Due: 12/31/17

Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin

Phase: N/A Priority: Normal
NCT ID: NCT04549363 Org: User:
Start: 12/21/20 End: 11/21/22 Due: 11/21/23

Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02631538 Org: User:
Start: 02/17/16 End: 06/23/20 Due: 06/23/21

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Phase: N/A Priority: Normal
NCT ID: NCT01668654 Org: User:
Start: 09/04/12 End: 06/18/13 Due: 06/18/14